SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias board investigation into CEO Jensen Huangs acknowledged relationship with a woman reported to have suspected ties to Chinese intelligence is driving attention, with traders debating possible governance, national-security and leadership fallout. Reactions are split between calls to sell over the uncertainty and dip-buying on the view that the allegations do not change Nvidias underlying business.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs Nov. 22 decision on Capricors deramiocel for Duchenne muscular dystrophy, with the application now focused on HOPE-3 upper-limb-function data and a letter from 28 trial investigators urging approval. Many traders expect a favorable decision, while others emphasize the binary risk of a CRL and question whether the data address the FDAs concerns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios quarterly revenue miss and sequential sales decline have driven a sharp selloff, with traders also criticizing the lack of a conference call and clear commercial guidance. The reaction is divided: bears question Anktivas adoption and execution, while bulls point to the positive BCG-naive trial endpoint and recent label expansion as longer-term offsets.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTD is drawing attention ahead of its quarterly results, with traders debating whether the recent rebound and heavy short positioning could support further gains or whether weak results or guidance will trigger another selloff. Some view co-founder Dave Pickles return to a technology leadership role as a potential turnaround signal, while skeptics remain concerned about ad-spend growth and management execution.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

A quarterly earnings beat and a further increase to Constellations full-year outlook are driving attention, reinforcing traders view that the company can benefit from growing AI data-center demand for reliable nuclear power. Many are bullish on the outlook, though some are frustrated that the shares have not rallied more strongly despite the results.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics better-than-expected Q3 revenue and higher 2026 outlook, driven by BRIUMVIs growth, are the main focus. Traders broadly praise the commercial momentum but debate the muted share-price reaction and possible sell-the-news pressure, while looking to Phase 3 data for subcutaneous BRIUMVI as a future catalyst.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is drawing attention for clinical updates across its pipeline, especially CTX310 data showing substantial reductions in triglycerides and ANGPTL3, alongside encouraging early zugo-cel results in autoimmune disease. Traders view the readouts as validation of the companys programs, while some question whether early-stage results can drive a lasting share-price revaluation.

NRG Energy, Inc. engages in the production, sale, and distribution of energy and energy services. It operates through the following segments: Texas, East, West/Services/Other, Vivint Smart Home, and Corporate Activities. The Texas segment includes all activities related to customer, plant and market operations in Texas, other than Cottonwood. The East segment engages in all activities related to customer, plant and market operations in the East. The West/Services/Other segment is focused on all activities related to customer, plant and market operations in the West and Canada, and activities related to the Cottonwood facility and other investments. The Vivint Smart Home segment is a smart home platform that provides customers with technology, products and services to create a smarter, greener, safer home. The company was founded in 1989 and is headquartered in Houston, TX.

NRG Energy Inc.

NRG is drawing attention after a Q3 earnings beat and an agreement to sell six gas-fired plants, with the proceeds expected to support buybacks and debt reduction. Traders largely welcomed the news, though some noted the sale also gives up the plants future earnings.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention around its earnings, with traders weighing an EPS miss against its gold holdings and longer-term gold and copper production prospects. Discussion also reflects strength in gold miners as gold rises, alongside bearish views that the stocks correction may continue.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 470,828,218.2922282 with 445,826,218.2922282 in circulation. The last known price of Avalanche is 7.96863632 USD and is down -2.75 over the last 24 hours. It is currently trading on 1134 active market(s) with $204,104,522.93 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

AVAXs steep pullback and volatile swings are dominating discussion, with traders often blaming weakness in Bitcoin and the broader altcoin market. Sentiment is divided between holders buying the dip and traders warning that the decline could continue, with some viewing rebounds as short-lived pumps.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IONS plunges ~19% premarket after cutting 2026 TRYNGOLZA sales guidance to ~$50M (from $100-110M) on a slower sHTG launch (Q3 sales just $9M). $DBX slips 3% on $1B convertible bond raise for debt paydown and buybacks. $LUNR selected for NASA’s CLPS 2 lunar delivery contract. https://notreload.xyz/wall-street-live-monday-november-9/

BioSwings™

05:52 AM - The Dow, S&P 500 and Nasdaq are expected to open mixed as investors assess developments involving Nvidia CEO Jensen Huang and evaluate the extent of last week's market selloff.

NOTRELOAD AI

Wall Street Live - Monday, November 9

StockTwits Web

Ionis Pharmaceuticals Inc

Dropbox Inc

Intuitive Machines Inc

 plunges ~19% premarket after cutting 2026 TRYNGOLZA sales guidance to ~$50M (from $100-110M) on a slower sHTG launch (Q3 sales just $9M). 

 slips 3% on $1B convertible bond raise for debt paydown and buybacks. 

 selected for NASA’s CLPS 2 lunar delivery contract. 